See other companies on Otta

Lindus Health

Clinical trial platform

21-100 employees
  • Healthcare
  • B2B
  • Recruitment
  • Science
  • MedTech
Weston St, London SE1 3ER

Jump to section

Company mission

To accelerate clinical trials, so patients can benefit from new treatment sooner.

Top investors

50% female employees

Otta's take

Sam Franklin headshot

Sam Franklin

CEO of Otta

Traditional clinical research companies are often inefficient and rely upon pen and paper, even for the UK COVID-19 vaccine trial, one of the best-funded trials in history. In addition, the cost of conducting clinical trials has skyrocketed over the last decade. This stifles innovation and means fewer new treatments for patients.

In response to these challenges, Lindus Health was established with the mission to simplify patient participation in research and expedite the development of novel treatments. On a mission to change how trials are conducted in order to provide faster, safer clinical trials on behalf of companies developing new treatments, and lowering the barriers to participation for patients.

Since launching in 2021, Lindus Health has actively connected patients with clinical trials across diverse domains, encompassing areas such as type 2 diabetes, COVID-19 diagnostics, and mental health. Bolstered by a successful funding round, the company is poised to facilitate end-to-end clinical trials and research sponsors with high-quality data. Alongside this growth, Lindus is gearing up to expand its workforce. This strategic approach underscores its commitment to reshaping the landscape of clinical research for the betterment of patients and the advancement of medical science.

Benefits

  • Generous stock options (we will also pay your professional fees)
  • Unlimited holidays; everyone is encouraged to take off at least 28 days each year
  • Flexible office arrangement; you are encouraged to work 3-4 days per week in our office in London (near London Bridge) when you start, but you are free work flexibly once you've had a chance to get to know everyone
  • Regular team events; recently we've been to Legoland, a Bake Off competition, and a Millwall FC home game (decided by popular vote)
  • Up to £1,000 per year towards courses and development
  • A new laptop as your main workstation and up to £500 towards setting up your home office
  • Employee benefits program including free Netflix and Spotify

Company values

  • Be transparent: We share information across the whole team, avoiding hierarchies and silos
  • Stay curious: Keep asking questions, we'll never get anywhere by blindly following the status quo
  • Be high-agency: Nothing happens unless we make it happen, and we all take ownership and responsibility
  • Go fast: Speed is life and our biggest competitive advantage, get used to faster OODA loops
  • Benefit patients: Our most critical mission is to accelerate clinical trials so patients can benefit
  • Have fun: Most importantly, we are in the pursuit of fostering a fun environment for all

Funding (last 2 of 3 rounds)

Aug 2023

$18m

SERIES A

Jun 2023

$0.7m

GRANT

$23.7m

Total funding

This company has top investors

Founders

Meri Beckwith

(Co-founder)

Previously a venture capital investor and partner to biotech and digital health companies including Attest, Latent Logic, Helloself and CoMind.

Michael Young

(Co-founder)

Previously Special Adviser to the UK Prime Minister, where he advised the UK government on life sciences. Former management consultant at McKinsey and LEK.

Nik Haldimann

(Co-Founder & CTO)

Product-minded software engineer and engineering leader, previously at BenevolentAI, Descartes Labs, Placemeter and Google

Lindus Health 1